Compare Echo Therapeutics vs EndGenitor Technologies
Customers evaluate the quality of Echo Therapeutics's products using the following success metrics.
Overview
Echo Therapeutics is 35 yrs old and is based in United States.
Echo Therapeutics is a company focused on health technology, specifically in the domain of non-invasive continuous glucose monitoring. The company's main offering is a wireless system that allows individuals to monitor their glucose levels continuously and non-invasively, with the data being accessible on any mobile platform or from the cloud for remote monitoring. Echo Therapeutics primarily sells to the outpatient diabetes market, the fitness and weight loss industry, and the personal lifestyle wearable-health space. It was founded in 1989 and is based in Franklin, Massachusetts.
EndGenitor Technologies is based in United States
EndGenitor scientists are also engaged in exciting research to novel methods for stimulating and promoting blood vessel formation and growth.
Demo Video
Leadership
Patrick T. Mooney (Chief Executive Officer, President)
Funding
Investors
Sherbrooke Capital, Nite Capital Management
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Echo Therapeutics has not claimed their profile.
Work for Echo Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Echo Therapeutics?
Claim your profile now.
Information not available because EndGenitor Technologies has not claimed their profile.
Work for EndGenitor Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for EndGenitor Technologies?
Claim your profile now.
Expert Collections
Digital Health
10,585 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.